Dilliott A, Costanzo M, Bandres-Ciga S, Blauwendraat C, Casey B, Hoang Q
Neurol Genet. 2025; 11(2):e200246.
PMID: 39996130
PMC: 11849525.
DOI: 10.1212/NXG.0000000000200246.
Qin W, Li F, Liu W, Li Y, Cao S, Wei Y
Alzheimers Dement. 2025; 21(2):e14486.
PMID: 39907198
PMC: 11851144.
DOI: 10.1002/alz.14486.
Tan Z, Ping J, Zhang Y, Kong C, Luo J, Liu X
Front Psychiatry. 2025; 15:1469671.
PMID: 39876995
PMC: 11772356.
DOI: 10.3389/fpsyt.2024.1469671.
Mancl J, Liang W, Bayhi N, Wei H, Carragher B, Potter C
bioRxiv. 2025; .
PMID: 39803525
PMC: 11722313.
DOI: 10.1101/2024.12.30.630732.
Hammers D, Eloyan A, Thangarajah M, Taurone A, Beckett L, Gao S
Alzheimers Dement. 2024; 21(1):e14218.
PMID: 39711228
PMC: 11772709.
DOI: 10.1002/alz.14218.
AlzGenPred - CatBoost-based gene classifier for predicting Alzheimer's disease using high-throughput sequencing data.
Shukla R, Singh T
Sci Rep. 2024; 14(1):30294.
PMID: 39639110
PMC: 11621786.
DOI: 10.1038/s41598-024-82208-x.
Identifying Alzheimer's disease-associated genes using PhenoGeneRanker.
Rahman M, Saeed F, Bozdag S
bioRxiv. 2024; .
PMID: 39605436
PMC: 11601490.
DOI: 10.1101/2024.11.12.623269.
LIMO-GCN: a linear model-integrated graph convolutional network for predicting Alzheimer disease genes.
Lin C, Li H, Wang J
Brief Bioinform. 2024; 26(1).
PMID: 39592152
PMC: 11596108.
DOI: 10.1093/bib/bbae611.
Aggregating amyloid resources: A comprehensive review of databases on amyloid-like aggregation.
Iglesias V, Chilimoniuk J, Pintado-Grima C, Barcenas O, Ventura S, Burdukiewicz M
Comput Struct Biotechnol J. 2024; 23:4011-4018.
PMID: 39582896
PMC: 11585477.
DOI: 10.1016/j.csbj.2024.10.047.
Autophagy-lysosomal pathway impairment and cathepsin dysregulation in Alzheimer's disease.
Mancano A, Pina J, Froes B, Sciani J
Front Mol Biosci. 2024; 11:1490275.
PMID: 39544403
PMC: 11560772.
DOI: 10.3389/fmolb.2024.1490275.
Proteomic analysis of APOEε4 carriers implicates lipid metabolism, complement and lymphocyte signaling in cognitive resilience.
Walker K, An Y, Moghekar A, Moaddel R, Duggan M, Peng Z
Mol Neurodegener. 2024; 19(1):81.
PMID: 39482741
PMC: 11526661.
DOI: 10.1186/s13024-024-00772-2.
Proteogenomic Approaches for Diseasome Studies.
Pokhriyall M, Shukla N, Singh T, Suravajhala P
Methods Mol Biol. 2024; 2859:253-264.
PMID: 39436606
DOI: 10.1007/978-1-0716-4152-1_14.
Association of common and rare variants with Alzheimer's disease in more than 13,000 diverse individuals with whole-genome sequencing from the Alzheimer's Disease Sequencing Project.
Lee W, Choi S, Shea M, Cheng P, Dombroski B, Pitsillides A
Alzheimers Dement. 2024; 20(12):8470-8483.
PMID: 39428839
PMC: 11667527.
DOI: 10.1002/alz.14283.
Further validation of the association between haplotype-tagging polymorphisms and Alzheimer's disease: neuropsychological tests, cerebrospinal fluid biomarkers, and genotype.
Babic Leko M, Spanic Popovacki E, Willumsen N, Nikolac Perkovic M, Pleic N, Zubcic K
Front Mol Neurosci. 2024; 17:1456670.
PMID: 39386049
PMC: 11461444.
DOI: 10.3389/fnmol.2024.1456670.
Single-Cell Cortical Transcriptomics Reveals Common and Distinct Changes in Cell-Cell Communication in Alzheimer's and Parkinson's Disease.
Bars S, Glaab E
Mol Neurobiol. 2024; 62(3):2655-2673.
PMID: 39143450
PMC: 11790751.
DOI: 10.1007/s12035-024-04419-7.
Low-Density Lipoprotein Receptor-Related Protein 1 as a Potential Therapeutic Target in Alzheimer's Disease.
Petralla S, Panayotova M, Franchina E, Fricker G, Puris E
Pharmaceutics. 2024; 16(7).
PMID: 39065645
PMC: 11279518.
DOI: 10.3390/pharmaceutics16070948.
Associations of cerebral amyloid beta and tau with cognition from midlife.
Gonzales M, ODonnell A, Ghosh S, Thibault E, Tanner J, Satizabal C
Alzheimers Dement. 2024; 20(9):5901-5911.
PMID: 39039896
PMC: 11497641.
DOI: 10.1002/alz.14060.
The Neurodegenerative Disease Knowledge Portal: Propelling Discovery Through the Sharing of Neurodegenerative Disease Genomic Resources.
Dilliott A, Costanzo M, Bandres-Ciga S, Blauwendraat C, Casey B, Hoang Q
medRxiv. 2024; .
PMID: 38853922
PMC: 11160810.
DOI: 10.1101/2024.05.27.24307990.
Mitochondrial alterations in fibroblasts from sporadic Alzheimer's disease (AD) patients correlate with AD-related clinical hallmarks.
Eysert F, Kinoshita P, Lagarde J, Lacas-Gervais S, Xicota L, Dorothee G
Acta Neuropathol Commun. 2024; 12(1):90.
PMID: 38851733
PMC: 11161956.
DOI: 10.1186/s40478-024-01807-x.
Learning semi-supervised enrichment of longitudinal imaging-genetic data for improved prediction of cognitive decline.
Seo H, Brand L, Wang H
BMC Med Inform Decis Mak. 2024; 24(Suppl 1):61.
PMID: 38807132
PMC: 11134626.
DOI: 10.1186/s12911-024-02455-w.